VEGFA and myeloid sarcoma: – BBB hyperpermeability. – Decreased expression of TJ proteins (ZO-1, occludin and claudin-5) in ECs in patients with active and inactive lesions. – Rodent model of MS show increased expression of VEGF in ECs, astrocytes and monocytes. – Increased vascular network density and angiogenesis.